MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Natural Science Foundation (16ZR1434000)
- China Postdoctoral Science Foundation (2014M550250, 2015T80455)
This publication has 35 references indexed in Scilit:
- Supporting Role for GTPase Rab27a in Hepatitis C Virus RNA Replication through a Novel miR-122-Mediated EffectPLOS Pathogens, 2015
- The role of Rab27a in the regulation of neutrophil functionCellular Microbiology, 2014
- Rab27a Supports Exosome-Dependent and -Independent Mechanisms That Modify the Tumor Microenvironment and Can Promote Tumor ProgressionCancer Research, 2012
- Cancer stem cells trackedNature, 2012
- The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesisCellular and Molecular Life Sciences, 2012
- MicroRNA‐199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer‐initiating cellsThe FEBS Journal, 2012
- Tumorigenesis: Testing ground for cancer stem cellsNature, 2011
- Invitation to a second roundNature, 2010
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences, 2007
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003